Back to search
FDAFDA · Food and drugs·Recall number Z-2622-2024

Product Name: Salivary Testosterone ELISA Model/Catalog Number: SLV-3013 Product Description: An enzyme immunoassay for the quantitative in vitro diagnostic measurement of free active testosterone in saliva.

Published August 21, 2024 · Recall initiated: July 5, 2024

Summary

FDA records medical device Class III recall Z-2622-2024, published August 21, 2024 and initiated July 5, 2024. Recalling firm: DRG International, Inc.; Status: Ongoing; Reported quantity: 257 units; Lot: Model/Catalog Number: SLV-3013; UDI-DI: 04048474030136; Lot Nymbers: 66K014 and 66K123. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DRG International, Inc.
Distributor
US Nationwide distribution in the states of CA, IL, MN, PA, UT, VA.
Lot
Model/Catalog Number: SLV-3013; UDI-DI: 04048474030136; Lot Nymbers: 66K014 and 66K123.
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Product Name: Salivary Testosterone ELISA Model/Catalog Number: SLV-3013 Product Description: An enzyme immunoassay for the quantitative in vitro diagnostic measurement of free active testosterone in saliva. recalled?

Yes. FDA published recall Z-2622-2024 on August 21, 2024. Reported hazard: Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.

What should I do if I have this product?

Voluntary: Firm initiated · Letter